News
LACNETS Offers Education Grants for 2018 NCAN National NET Patient Conference
Would you like to attend the 2018 NCAN National NET Patient Conference in Las Vegas, September 27-29, but are concerned about costs? LACNETS, the Los Angeles Carcinoid Neuroendocrine Tumor Society, is offering Education Grants in the amount of $1,000…
READ MOREA Journey of Hope: Moving Toward a Brighter Future in Neuroendocrine Tumor (NET) Treatment
A newly-released, must-read about five neuroendocrine tumor patients, each with different experiences with Peptide Receptor Radionuclide Therapy (PRRT). With a foreword, “Hope is Like Air,” by neuroendocrine cancer specialist Eric Liu, MD,…
READ MORELaugh and Learn with Comedian Steve Mazan
Come and laugh with Steve Mazan, stand-up comedian, inspirational speaker, and 13-year NET cancer survivor. “CS Happens” is a Laugh and Learn special evening for the NET community, and is complementary courtesy of Lexicon Pharmaceuticals. This unique…
READ MOREPatient & Caregiver Education on Carcinoid Syndrome: Talking to Your Doctor About Symptoms, Diet, and Treatment
Last spring, we were pleased to create an interactive resource for people living with Carcinoid Syndrome with our partner CancerCoachLive – we’ve teamed up again to create a new virtual education program that will provide a detailed walk-through…
READ MORENET Patient Research Study in New York City, May 3
Do you live in or near New York City – here’s a great opportunity to participate in a neuroendocrine tumor (NET) research study on Thursday, May 3 in Manhattan. You can make a difference for NET patients by sharing your opinions on a device in development …
READ MOREEndocrinology Society Recognizes Neuroendocrine Cancer Physician and Researcher for Excellence at 2018 Annual Meeting
Congratulations to Amit Tirosh, MD, neuroendocrine cancer physician and researcher, whose work was recognized for excellence at the Endocrinology Society’s 2018 Annual Meeting. Dr. Tirosh will soon be establishing and leading a new NET center at …
READ MOREPlease Help Pass a Bill That Could Result in Early Diagnosis for Neuroendocrine Cancer Patients — Deadline Extended to April 16
NET patients, friends and families – we need your help! Greta Stifel, founder of the Stifle Cancer Foundation, NET patient thriver, advocate and political activist, has created and submitted to the State of Connecticut Public Health Committee and…
READ MOREPlease Help Pass a Bill That Could Result in Earlier Diagnosis for Neuroendocrine Cancer Patients
NET patients, friends and families – we need your help! Greta Stifel, founder of the Stifle Cancer Foundation, NET patient thriver, advocate and political activist, has created and submitted to the State of Connecticut…
READ MOREClinical Nurse Educator Program Established for Neuroendocrine Tumor Patients on Xermelo
Are you a neuroendocrine tumor patient who is taking or has been prescribed Xermelo? Lexicon Pharmaceuticals is now offering a new Clinical Nurse Educator Program (CNE) available to you at no charge. Click here to read more…
READ MOREExciting News about Edward M. Wolin, MD, CCF’s Co-Medical Director
It is with great pleasure that the Carcinoid Cancer Foundation announces that Edward M. Wolin, MD, Co-Medical Director of CCF, has been named Director of the Center for Carcinoid and Neuroendocrine Tumors at The Mount Sinai Hospital in New York City, …
READ MORE